Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Johnson & Johnson

http://www.jnj.com

Latest From Johnson & Johnson

Regeneron, Pfizer Tout Potential BCMA Bispecific Advantages At ASCO

Regeneron presented data for linvoseltamab, while Pfizer presented data for elranatamab, including in patients who previously received BCMA-directed therapy. 

ASCO Clinical Trials

Allogene May Have Cracked The Off-The-Shelf CAR-T Problem

Allogeneic candidate’s durability is holding up thanks to a novel conditioning regimen, but Phase II data will be crucial test.

Commercial Clinical Trials

AstraZeneca’s Lynparza Adds Narrow Prostate Cancer Indication

AstraZeneca had hoped data from Phase III PROpel would lead to an all-comers indication in first-line, metastatic castration-resistant prostate cancer, but new indication is limited to BRCA mutations.

Approvals Business Strategies

AstraZeneca’s IBD Hopes Deflated Amid Evolving Market And Pipeline Competition

The major’s attempt to break into Crohn’s disease and ulcerative colitis has been cut short as a highly competitive market and pipeline, intensified by the entrance of biosimilars, renders further development of brazikumab impractical.

Gastrointestinal Immune Disorders
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Medical Devices
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Abiomed, Inc.
    • Acclarent Inc.
    • Actelion Pharmaceuticals Ltd.
    • AdvanceCOR GmbH
    • ALZA Corporation
    • Alios BioPharma, Inc.
    • Animas Corporation
    • Aragon Pharmaceuticals, Inc.
    • Auris Health, Inc.
    • Auris Surgical Robotics
    • BeneVir Biopharm, Inc.
    • BioMedical Enterprises, Inc.
    • Biosense Webster, Inc.
    • Calibra Medical, Inc.
    • Centyrex Internal Venture
    • Cilag AG
    • Cerenovus
    • Codman & Shurtleff, Inc
    • Coherex Medical, Inc.
    • Conor Medsystems, Inc.
    • Cordis Webster, Inc.
    • CorImmun GmbH
    • Cougar Biotechnology, Inc.
    • Covagen AG
    • Crucell N.V.
    • DePuy Mitek, Inc.
    • DePuy Orthopaedics, Inc.
    • DePuy Synthes, Inc.
    • Ensure Medical
    • Ethicon, Inc.
    • FemRx Inc.
    • Flexible Stenting Solutions, Inc.
    • Gynecare, Inc.
    • Hansen Medical, Inc.
    • Innovative Surgical Solutions, LLC
    • Interventional Spine, Inc.
    • Janssen Biotech, Inc. (formerly Centocor Ortho Biotech Inc.)
    • Janssen Diagnostics
    • Janssen Pharmaceuticals
    • Janssen Vaccines & Prevention B.V.
    • JointPoint, Inc.
    • LifeScan, Inc.
    • Medical Enterprises Distribution, LLC
    • Medos International SARL
    • Megadyne Medical Products, Inc.
    • Mentor Corporation
    • Micrus Endovascular Corporation
    • Molsaic Internal Venture
    • Momenta Pharmaceuticals, Inc.
    • NeoStrata Company, Inc.
    • Neuravi Limited
    • NeuWave Medical, Inc.
    • Novira Therapeutics
    • Omrix Biopharmaceuticals, Inc.
    • Ortho Biotech Products, L.P.
    • Ortho-McNeil, Inc.
    • Orthotaxy
    • Peninsula Pharmaceuticals, Inc.
    • Pulsar Vascular Inc
    • RespiVert Ltd.
    • Scios, Inc.
    • Selected Nerve Stimulation Internal Ventures
    • Sentio, LLC
    • Sequus Pharmaceuticals
    • Stem Cell Internal Venture
    • Synthes, Inc.
    • Tibotec
    • Torax Medical, Inc.
    • Triage Medical, Inc.
    • Verb Surgical Inc.
    • Veridex
    • Vigor Sub, Inc.
    • Vistakon
    • XO1 Limited
    • TARIS Biomedical LLC
    • Verb Surgical, Inc.
UsernamePublicRestriction

Register